Speakers
Keynote Presentations
Could a new vaccine candidate really be a gamechanger? Promising results from a recent phase 1 clinical trial suggest we may be able to drive immune responses in predictable ways and significantly speed up the pace of vaccine research.
Dennis Burton is Professor of Immunology and Microbiology at the Scripps Research Institute in La Jolla, California; Member of the Steering Committee of the Ragon Institute of MGH, MIT and Harvard; Scientific Director of the Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative and Director of the NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery at The Scripps Research Institute. He received a B.A. degree in Chemistry from the University of Oxford and a Ph.D. degree in nuclear magnetic resonance in biology from the University of Lund, Sweden. His early work focused on understanding antibody effector function and he was one of the co-discoverers of the complement and Fc receptor binding sites on immunoglobulin G.